MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
GRCE Grace Therapeutics
- 3.820
- -0.240-5.91%
Close Dec 20 16:00 ET
- 3.820
- 0.0000.00%
Post 20:01 ET
38.73MMarket Cap-4.20P/E (TTM)
4.170High3.820Low30.58KVolume4.170Open4.060Pre Close122.40KTurnover0.66%Turnover RatioLossP/E (Static)10.14MShares4.96552wk High0.69P/B17.75MFloat Cap1.98052wk Low--Dividend TTM4.65MShs Float2016.000Historical High--Div YieldTTM8.62%Amplitude1.720Historical Low4.002Avg Price1Lot Size
About Grace Therapeutics Company
Grace Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002, and is headquartered in Princeton, NJ.
Company Profile
SymbolGRCE
Company NameGrace Therapeutics
Listing DateJan 7, 2013
Founded2002
CEOMr. Prashant Kohli
MarketNASDAQ
Employees7
Fiscal Year Ends03-31
Address103 Carnegie Center,Suite 300
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540
Phone1-818-839-4378
Websitehttp://www.gracetx.com
Company Executives
- Name
- Position
- Salary
- Prashant Kohli
- Chief Executive Officer and Director
- 987.63K
- Dr. R. Loch Macdonald, M.D.,PhD
- Chief Medical Officer
- --
- Robert J. DelAversano
- Vice President, Finance, Principal Financial Officer and Principal Accounting Officer
- --
- Carrie D'Andrea
- Vice President, Clinical Operations
- 383.00K
- Amresh Kumar, PhD
- Vice President, Program Management
- 378.02K
- Vimal Kavuru
- Chairman of the Board
- 127.43K
- Dr. S. George Kottayil, PhD
- Director
- 44.90K
- Edward Neugeboren
- Independent Director
- 53.00K
- A. Brian Davis
- Independent Director
- 57.50K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.